IDEXX Laboratories (IDXX) News
NASDAQ: IDXXHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
518.00+4.86 (+0.95%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
IDXX news summary
We found 33 recent headlines mentioning IDEXX Laboratories (IDXX): 0 in the past week and 7 in the past 30 days, most often from Seeking Alpha, Nasdaq. For price context, IDXX is up 0.95% at $518.00. The most recent story, "Should You Continue to Hold IDXX Stock in Your Portfolio?", was published by Nasdaq on Sep 23, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest IDEXX Laboratories headlines
- Should You Continue to Hold IDXX Stock in Your Portfolio?IDEXX's CAG growth, expanding software adoption and global gains face headwinds from FX and weaker U.S. vet visits.NasdaqIDXX, TFX, GMED, VCYT
- IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth TargetsThese 3 Water ETFs Could be Quiet Winners From Infrastructure SpendingIDEXX Laboratories (NASDAQ:IDXX) executives highlighted the company’s diagnostic innovation pipeline, recurring-revenue…Nasdaq
- IDEXX Highlights Diagnostics Growth Drivers, Cancer Testing at Morgan Stanley ConferenceThese 3 Water ETFs Could be Quiet Winners From Infrastructure SpendingIDEXX Laboratories (NASDAQ:IDXX) executives reiterated the company’s long-term growth framework at the Morgan Stanley…NasdaqIDXX, MS
- 10 large and mega-cap U.S. healthcare stocks with the weakest momentum gradesSeeking Alpha
- IDEXX Stock Gains Following the Acquisition of CoVetIDXX shares rise 0.6% after the company acquires CoVet, expanding its AI-native software capabilities to improve veterinary workflows, diagnostics and practice performance.NasdaqIDXX, TFX, GMED, VCYT
- IDEXX Buys CoVetAI To Expand Veterinary Workflow Intelligence(RTTNews) - Veterinary diagnostics company IDEXX Laboratories, Inc. (IDXX) announced on Wednesday that it has acquired CoVetAI Inc., a provider of AI-native ambient listening and clinical workflow…Nasdaq
- IDEXX Laboratories, Inc. (IDXX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking AlphaIDXX, MS
- Insider Alert: IDEXX Director Lawrence Kingsley Sells $1.2 Million of StockKey PointsThe transaction involved 2,203 shares at $532.08 per share for a total value of ~$1.2 million.Nasdaq
- Idexx (IDXX) Down 7.8% Since Last Earnings Report: Can It Rebound?Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.NasdaqIDXX, GKOS
- Idexx Laboratories (IDXX) is a Top-Ranked Growth Stock: Should You Buy?Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.Nasdaq
- Here's Why Idexx Laboratories (IDXX) is a Strong Momentum StockWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.Nasdaq
- Is it a Prudent Move to Retain IDEXX Stock in Your Portfolio Now?IDXX's CAG diagnostics and cloud software growth support recurring revenues, while FX exposure and distributor inventory swings remain key risks.NasdaqIDXX, TFX, GMED, VCYT
- IDXX Raises 2026 EPS Outlook as Diagnostic Growth and Margins ImproveIDEXX raises its 2026 EPS outlook as recurring diagnostics growth, wider margins and international expansion offset softer U.S. veterinary traffic.NasdaqIDXX, ABT, LH
- Is IDXX Worth Buying as Growth Strength Meets a Premium Valuation?IDEXX pairs resilient diagnostics growth, margin gains and expanding innovation with a premium valuation that supports a hold-or-wait stance.NasdaqIDXX, DXCM, INGN
- IDEXX Laboratories, Inc. (IDXX) Analyst/Investor Day TranscriptSeeking Alpha
- IDEXX Labs Executing, But Valuation Continues To Weigh On That ExecutionSeeking Alpha
- IDEXX Laboratories Targets $45B Pet Diagnostics Opportunity With AI, Cancer TestsThese 3 Water ETFs Could be Quiet Winners From Infrastructure SpendingIDEXX Laboratories (NASDAQ:IDXX) outlined an innovation-led growth strategy at its 2026 Investor Day, highlighting a $45 billion…Nasdaq
- IDEXX Laboratories, Inc. (IDXX) Analyst/Investor Day - SlideshowSeeking Alpha
- Here's Why Idexx Laboratories (IDXX) is a Strong Growth StockThe Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.Nasdaq
- IDEXX (IDXX) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- IDEXX Laboratories: Worth The PremiumSeeking Alpha
- IDEXX Laboratories, Inc. (IDXX) Q2 2026 Earnings Call TranscriptSeeking Alpha
- IDEXX Laboratories Does Not Need More Vet Visits, But It Needs More Tests Per VisitSeeking Alpha
- IDEXX Laboratories, Inc. (IDXX) Presents at Stifel Jaws & Paws Conference 2026 TranscriptSeeking Alpha
- IDEXX Laboratories, Inc. 2026 Q1 - Results - Earnings Call PresentationSeeking Alpha
- IDEXX Laboratories, Inc. (IDXX) Q1 2026 Earnings Call TranscriptSeeking Alpha
- IDEXX Laboratories Vs. Zoetis: A Pre-Earnings ComparisonSeeking AlphaIDXX, ZTS
- IDEXX Laboratories, Inc. (IDXX) Presents at 47th Annual Raymond James Institutional Investor Conference - SlideshowSeeking Alpha
- IDEXX Laboratories, Inc. (IDXX) Presents at 47th Annual Raymond James Institutional Investor Conference Prepared Remarks TranscriptSeeking Alpha
- IDEXX Laboratories, Inc. (IDXX) Presents at BofA Securities Animal Health Summit TranscriptSeeking Alpha
- IDEXX: A Great Business Trapped By A Demanding ValuationSeeking Alpha
- IDEXX Laboratories, Inc. (IDXX) Q4 2025 Earnings Call TranscriptSeeking Alpha
- IDEXX Laboratories, Inc. 2025 Q4 - Results - Earnings Call PresentationSeeking Alpha